NTHL1 and neoplastic syndrome: Biallelic NTHL1 mutations are responsible for the NTHL1-tumor syndrome, a cancer-predisposing disease characterized by the occurrence of adenomatous polyposis and cancer at different sites, in addition to CRC [38].